Δελτίο Νοσοκομειακής Φαρμακευτικής, τεύχος 30
of 48
description
Δελτίο Νοσοκομειακής Φαρμακευτικής, τεύχος 30
Transcript of Δελτίο Νοσοκομειακής Φαρμακευτικής, τεύχος 30
-
| 30 | I 2014
(.....): 99, 115 27,
15
018673
ESOP, 23-24 2014
19 EAHP, 26-28 2014
. .
-
4
6 |
5 | editorial
14 |
18 | -
32 |
36 |
44 | -
6 | ... 6 | ..... 2014 7 | 1 ! 10 | ... ! 11 | ... 12 | . .
5 | ...
14 |
18 | 28 : 22 | 26 |
32 | &
35 |
36 | ESOP...37 | SOP 40 | 19o EAHP ( 26-28/03/2014): 2020
44 | - Workshop (, 8 2014): :
16 |
16 |
| 30I 2014
..... : : . : : : : : , ,
..... 99, 115 27, ./fax: 210 7753104e-mail: [email protected]://www.pefni.gr
I
-
K
, , ,
, . . .
: , , ,
:
:PressiousArvanitidis
& :
.: 210 28.29.552, 28.43.871
-
5 - - 2014
editorial
... 1 . - . . , , -. . , , , , . . in , . , - . - : O -- ( -- ).
O .., - .. 108/93 ( ). , , .
O ( -) .. ..., - -. - , .
O - ( -).
O - .
- . - ,
( ), - . - ( .. ) . ..... -. O (- 2013), .
O 3 -- ( 2013).
O 6 -, - ( 2013).
O E.S.O.P. (- ) - , ( 2014).
O .... , - (- 2014).
O - (.., -, TACD, , ).
2014 - ( ). , ... () ... - . . . , . , - .
.....
-
6
- !!! ..... :
To ...
, 13/01/2014. .: 511
: . : : 2/.. 119061/23-12-2013
,
, : , . . .
.. ..... .
..... 2014
15 2014, . : O 2013 O ( ) 2013 O 2014 O 2014. - ..... ..... . . , .. ..... .
: . - .
-
7 - - 2014
1 !
.. 3457/2014 ( 64/2014, 11 . 1) 36/7/22-01-2014. :
. . 3457
[...]
11 . 3816/2010
1. O - . 2 12 . 3816/2010. - , 60 . . 60 - . ( ), - , , .
-
8
, 31/01/2014. .: 516
: O . O .
: . 3816/2010
,
36/7/22-01-2014 - , .., . , - ' , - 1 . , , , . 1 . 3816/ 2010, - , (). ..... . 2 12 . 3816/2010. . . 3816/2010 , , - .
.. .....
.
- . , . ..... :
-
9 - - 2014
, 31/01/2014. .: 517
: O O &
: 1/. 3816/2010
. ,
36/7/22-01-2014 , 2013 ( ) 1 . 3816/2010, . 11, . 1 3457/2014 ( 64/2014) . .
.. .....
.
, .
-
10
, 20/02/14. .: 521
: .
:
, . 14230/11-02-2014 , , . -, :1. .2. .3. .4. .5. .6. , , .
-, , - , , . .
.. .....
.
... !
11/2/2014 . ..... ' 521/20/02/2014 , . , .
-
P6
/14
P6
/14
, 06/03/2014. .: 524
:O , . . O , . .
: 2
2 , , -, . , . 2 .
.. .....
.
....., , ' 524/06-03-2014 , - . ... .
11 - - 2014
...
-
12
. .
..... -, . A. , .
... ;
, -, , . - - . , , , - .
20 , 10 - 12 50 ; , - ;
. -, -
, - - . , .
Y ;
, , -. - . - , . , , - - . . .
, ..... . . 507/09-12-2013 .
-
;
- , , , -, . - . , . - .
;
- .
. .
13 - - 2014
. . - . ... . - . . ..... ..... - .
-
14
- (...) ... 24 2014 - , - , - . - ... .
... . , - - , ...
, - ... .
- ... . . ..., . . - -. , - , - - , -
-
. ( ) , , - . , , -, ...
- , ( , - ), , - .
..., . . - , : , ,
( ), - .
, ... . - , , . ... - ... - , .
-, ( ..., / , ) ... , - - . - .
... ... - - ( - - ... ) .
: ...
E ' ... -
15 - - 2014
V
-
16
, - , - . , - -, :)
, , . , :O O O O O O O &
O O (/ )
O -
O
O
O O -
O - .O .
) , - .. .
) .., - - , - .
) .
) - , , - .... ( ....) .
:) 162/1979 -
( 42 )) 768/1980 -
( 186 )) 1258/1981 - , - - (...), ( 309 ).
) . 3329/05 7 . 8 . 19.) 2, 12, . 1 , , 17 . 2 41 . 1,2,3 .1946/91.
! , . 5 , , , - , 20 . .
: ...
... !
-
18
-
28 :
28 .
5 10.000 (Orphan drug Regulation 141/2000). .
.
, . . , , . ,
.
6.000-8.000 , -. , - .
, - , - . - - .
- 25% 5 30 . 40% - , - .
350 -, 650.000 .
75% , 26% - 5 .
Q Charcot - Marie - Tooth Q Q Q Q Q Q Huntington Q Tarlov Q Kleine Levin Q Q Baker Q Milliossi Q Q Lowe Q Friedreich's Q Mobius Q Q Guillain - Barre Q Alzheimer Q Stiff Person Q Q Tourette Q Cornelia De Langue Q Gravis Q Costello Q Weber Q Lambert - Eaton Q Rett Q Dravet
( pespa)
-
19 - - 2014
-
Q Leber Q C.I.D.P. Q Arnold - Chiari Q Kearns - Sayre Q Q Duchene Q Miller Fisher Q Q Q M.E.R.R.F. Q Okamoto Q Steele - Richardson - Olszewski Q Strumpell - Lorain Q Werdnig - Hoffman
Q Q Q Q Q Takayasu Q Q Q Q P.F.A.P.A. Q Wegeners Q Q Adamantiades - Behcet Q Q Goodpasture Q Sjogrens Q Q Q Reynolds Q Q Ollier Q Churg - Strauss Q Q Lennox - Gastaut Q Q Q Q Castleman Q Q Q Q Devics
Q Q Crohn Q Q Wilson Q Q Q Whipple Q Peutz - Jeghers
Q Q Q Q Q V Q VQ V Q VIQ Q Q Q Maple Syrup Urine Q Alagille Q Fanconi Q Q Niemann - Pick Q Niemann - Pick B Q Niemann - Pick Q Q Fabry Q Gaucher Q Gaucher Q Gaucher Q Pompe Q Gitelman Q Bartter Q
( pespa)
ii
-
20
-
Q Q Pagets Q Q Q Q Gorham Q Q Jarcho - Levin
Q Q Kartagener Q
Q Q Q - Q Q Q Q Q
Q Addison Q Turner Q Angelman Q Q Cori Q Graves Q Cushing Q Q Klinefelter Q Prader Willi Q Q Hallermann - Streiff Q Noonan Q Pearson
Q Q
Q Netherton Q Q Q Q Q Q Q Vogt-Koyanagi-Harada Q
Q Q Q Von Hippel Lindau Q Hodgkins Q Sezary Q Q
Q Marfan Q Williams Q Q Jacobsen Q QT
( pespa)
-
21 - - 2014
-
-, 4 -, ( ), , Gaucher Pompe.
, .
200-300 . -
71 , 43 , 10 .
- 3816/10.
: ...
' ...
: eurordis.org | orphan.net | rarediseases.org | nih.gov | eespof.gr | pespa.gr
Jennie De Greef, Chief Operating Officer European Association of Hospital Pharmacists (EAHP), . ..... EJHP . EAHP :
EJHP"A new achievement is the first translation of a portion of the journal into the Greek language that happened as a result of sponsorship obtained for the translation. It is hoped that other translations will be made and BMJ is working on a way to make this happen."
-
22
-
(..) , 1:3.500 5% . , . , . , , , . ( ) , - CFTR (Cystic Fibrosis Transmembrane conductance Regulator), 7 .. 1989. , , - . .. - . - , . Staph. aureus Haem. influenzae, Pseudomonas aeruginosa, - . , -
..
.
..
-
23 - - 2014
-
, . - , , - . , Stenotrophomonas maltophilia, Alcaligenes xylosoxidans, . - Burkholderia cepacia . - - -. , -, , , , , , , CRP. (2%). - , , -. CT - , . - - - - (RV/TLC).H , -, FEV1, FVC, FEV1/FVC, VC TLV. - (DLCO) . - , , , . ,
. : O - O ( 38C) O O - O O O - / O O FEV1 O SatO2. - , -, , . , - . , , 20-30%. , 250ml ( ) 5% . , - . , . - () 1-15%. - .. - , IgE, - IgE IgG, , - ., (, -) , - . .. -, , ii
-
24
-
- - . 20% - . 85% , - ( 7%), - . (A,D,E,K). - . 15% . - (10-45%), (15%) . - - (
-
26
-
, -, - , -. - (ACCP, 1992). ( ) , .
- . Al-Shaqha & Zairi (2001), - :
. , . . , . . , . .
, , (Lazarou et al., 1998). , - (Doldi & Bratengeyer, 2005). , - , 1990 -New Economy (Elsner, 2004). - (mass production to mass customization)
-
27 - - 2014
-
. , standards.
O : . - - . - .
O ( - )
O : - , :
1. .
2. , . - .
3. , , - .
- - .
( )
. - 4 ( 2010). :
O , - . - , , ,
, --, - (Walters et al., 2002). , - (merit good), - ( & , 2004).
Dorsch (2000), - , -, . :
O , . - , - , - .
O , . - , , , .
O , . -
O , , , .
-, , -, , - (Ifet, 2009).
(2009), - :
O : , ii
-
28
-
. -
. -
. - , - - ( ., 2008). (mean) (Standard Deviation = SD) - . Students t-test, - (ANOVA), . - PASW Statistics v.18.0. - .....- & .....- .
286 88. O 37,5% ,
62,5% .O 36,5% 40 , 63,5% 40 .
O 47,7% , 29,5% , 19,3% -, 3,4% .
O 57,7% , 11,5% , 14,1% , 16,7% .
: i) P.A. Kostagiolas, K.D. Bairaktaris & D. Niakas, (2009) An Information Behavior Investigation of The Community Pharmacists in Greece for Developing Library and Information Service, Health Information and Library Journal, 27, pp. 46-56. ii) Zehnder S., Beutler M., Bruppacher R., Ehrenhofer T., Hersberger K (2004) Needs and use of drug information sources in community pharmacies: a questionnaire based survey in German-speaking Switzerland, Pharm World Sci, 26, 197-202. iii) Cheng R., Cook K., Dowman S., Lawn R., Leary J., Quinn T., Schroder K., Smith N., TordoffJ., (2005), Health Professionals: How do the assess new medicines, Pharm World Sci, 27, 236-242.
- 74 , - . 9 , - , , .. , -, / - (Likert scale) / .
O (experts), , .
O 286 - , , (Cronbachs-a).
:
. -
. -
-
29 - - 2014
-
O internet internet.
-
(), - , -, . - , , -
. :
.
.
. .
Hepler (1996) -
O 42,4% 301 600 , 29,4% 601 900 , 21,2% 101 300 , 7,1% 100 .
O 59,8% , 37,9% -, 2,3% internet.
O 50,0% internet , 6,0% , 12,8% , 1,2% internet.
O 100,0% , 50,0% , 54,5% e-mail, 10,2% , 88,6% - , 3,4% .
O - , / / .
O - - . (p-value
-
30
-
- , . - , . , - , .
, , - . (IT) - -. - -, Healink, Scholar Google ..
, - - . - , - .
.. ,
, e-mail: [email protected], .: +2661087402
.. ...
...
e-mail: [email protected], .: 213 2044261
, , - . Perri (1996), - , ( , - ..) - .
-. - .
.
-
32
E
&
- - . () . - - , - , - . - 1985 ().
, - , , - .
....
- ().
() , , .
-
33 - - 2014
E
, . , , , , , , , .
- . , / , , - () .
, - , (). - (, , , ). - , , . , - ml, gr, meq/kg . - 24 .
()
, - , , , . - , , , - /, , , , . .
, , - .
, . - - .
-
E
34
.
, . - , , . - - .
, - .
-, , .
- . - , . , , , .
25-40 - , 30-50 -, 5-10 (, ..), 10-20 5-15 . - . 4 , 1 - 1 , ).
. - , - - ERASMUS.
: ...
.. !
-
14 , 7-9 - 2014, - (poster).
E
35 - - 2014
-
36
ESOP
(European Society of Oncology Pharmacy - ESOP) 2000 - - (International Society of Oncology Pharmacy Practitioners - ISOPP). - ESOP 44 -.
ESOP - , - - / , - (pharmaceutical care).
SOP - ( 3 delegates) (1 - )
(Delegate Assembly), SOP. 3 .. ESOP.
2004, SOP Copernicus Agenda*, -, .
-, -, (QUAPOS, YELLOW HAND*, SPILL KIT* ..), ESOP - - - .
Q ESOP 2004.
Q Quapos 3 ( ) . & . 2005.
Q ..... ESOP, - (....) - .
* ESOP (http://www.esop.li).
-
37 - - 2014
SOP
25 ( 44 ) 23 & 24 2014 SOP Delegate Meeting. - 2013 European Society of Oncology Pharmacy (ESOP), - COP2 (European Conference of Oncology Pharmacy), 2014, -- SOP . , .., ..... . SOP Klaus Meier - . , SOP, - 3150 , (), - - (basic and advanced Masterclasses). , -
2013. COP2 ESOP 26-28 2014, - - . - (ECOP3) 2016 , 2016 -, - . , -, (projects) ESOP:
The Contamination Project
SOP Delegate Meeting 2012 . 19 14 - - LC/MS Duisburg - ii
-
38
( 2013). - , . , - COP2 . .
he Clean Working Project
, - . - . project . SOP Clean Working Kits Sandoz.
, - SOP (Yellow Hand Award) ECOP2 -. , -, , - , .. ESOP.
The Centers of Exchanges Project
, . / (Center of Exchange) SOP ( ), - - . - , . . Meier ESOP, ECOP2.
The Spill Kit Project
- Spill kit (= - ) - ESOP. - Spill Kits , - (.. Sandoz ). , :O ESMO (European Society of Medical Oncology)
ESOP -, , WHO (Union for International Cancer Control, Institute of Cancer Policy). -
The Yellow Hand Project
( ) - , . ( SOP) 50%. -
Highly potentmedicine. Handlewith care
/ , 10 .
,
.
. !
-
39 - - 2014
SMO-2014 - . - SMO (- , , ). ( 2 ) .
O : E - Protect-Visualize, - -, . Klaus Meier - ESOP - . Z European Guide
on Quality Improvement in Comprehensive Cancer Control (Can Con), - 2014-2017, EPAAC (European Partnership Action Against Cancer) 2013 -. ESOP , -. ESOP - Can Con, - . Per Hartvig Honor ECCO (European CanCer Organisation) , ESOP .
Z - HORIZON 2020 , - -. HORIZON 2020 , Sherif Kamal, - .
O : - ECOP 2016 ISOPP (International Society of Oncology Pharmacy Practitioners), -
- , . - .. ESOP, .
, ESOP o Per Hartvig-Honor - (Basic Masterclass) . Irena Netkov. , Klaus Meier Advanced Masterclass , .
- . ..... - . ESOP - . , he Clean Working Project, The Contamination Project, . , - ..... FYROM ( ESOP) Macedonia ( Delegate Meeting) . site ESOP.
: ...
... -
-
40
19 - (European Association of Hospital Pharmacists, EAHP) 26 28 2014 1700 63 ( - ), . workshops - - , -, . - , - (Risk Management), -, - .
, - . AHP - 2020 . Roberto Frontini, 27 , - - , - . 26 , Daan Crommelin , -
19o EAHP ( 26-28/03/2014) 2020
-
41 - - 2014
, . , Graham Walton -. , - .o Synergy . Duncan Mc Robbie - . - - workshops . , Thomas Langebner - : , - - . - - . -, (Good Practice Initiatives). - , , - , . - . 1 - 2 - . Roberto Frontini Richard Price (Policy and Advocacy Officer EAHP)
. - , . (G.A. - 2014). ..... , . , - AHP Jennie De Greef - , - 2015!
: ...
... -
19o EAHP
, . Roberto Frontini
-
42
19 EAHP , (poster), :
, ,
IV . .
-
-
44
- Workshop : , 8 2014
Janssen Cilag - workshop : - : . - workshop - , 8 2014, ..... . - , BSc, MEd, MBA, - - Management Development Institute (MDI), - , , - . ..... ... -- . -. ....., , - -, .
, . .
, , :1. ,
, - , . ( Goleman) - , - . - , , , - . , , , - , - , , .
2. - Harvard (win-win negotiations). win-win : ) - ) ) ) .
3. , -, - . . ii
-
ii
-
-
46
4. Cohen-Bradford (Cohen- Bradford Influence Model) : , , - , . .
, -, . - - .
, - , , . , , - , - . workshop - - .
: ...
' ... !
-
3 2014 ( ) 2-3 2014 ,
- St. George Lycabetous Hotel, 25-26 ,
ECRD 2014The European Conference on Rare Diseases & Orphan Products8-10 May 2014, Andel's Hotel, Berlin, Germany
ISPOR 19th Annual International Meeting Examining the role of big data in health care decision making 31/5-4/6 2014, Palais des Congres de Montreal, Montreal, Canada
ESOP: ESOP 2 The European Conference of Oncology Pharmacy 26-28 2014, Krakow, Poland
6th International Conference on Oxidative Stress in Skin Medicine and Biology 28-31 2014, [ ...]
5th ESWI Influenza Conference 14-17 September 2014, Riga, Latvia
